Literature DB >> 11545672

Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia.

L Shihabuddin1, M S Buchsbaum, E A Hazlett, J Silverman, A New, A M Brickman, V Mitropoulou, M Nunn, M B Fleischman, C Tang, L J Siever.   

Abstract

BACKGROUND: Schizotypal personality disorder (SPD) shares social deficits and cognitive impairment with schizophrenia, but is not typically characterized by frank psychosis. Because striatal size and functional activity have both been shown to be associated with psychotic symptoms, we carried out the first study of SPD to assess the caudate and putamen for comparison with findings in schizophrenia.
METHODS: Patients with SPD (n = 16), schizophrenic patients (n = 42), and age- and sex-matched normal control subjects (n = 47) were assessed with magnetic resonance imaging. All of the patients with SPD and subsamples of the schizophrenic patients (n = 27) and control subjects (n = 32) were also assessed with positron emission tomography using fluorodeoxyglucose F-18.
RESULTS: The relative size of the putamen in controls was significantly larger than in patients with SPD and significantly smaller than in schizophrenic patients, while the relative size of the caudate was similar in all 3 groups. Compared with control values, relative glucose metabolic rate in the ventral putamen was significantly elevated in patients with SPD and reduced in schizophrenic patients. When subsamples of schizophrenic patients (n = 10) and patients with SPD (n = 10) both of whom never received medication were compared, this pattern was more marked, with the highest value for the putamen being found in patients with SPD for the ventral slice and the lowest value for the right dorsal putamen.
CONCLUSIONS: Patients with SPD showed reduced volume and elevated relative glucose metabolic rate of the putamen compared with both schizophrenic patients and controls. These alterations in volume and activity may be related to the sparing of patients with SPD from frank psychosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545672     DOI: 10.1001/archpsyc.58.9.877

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  21 in total

Review 1.  Insights and treatment options for psychiatric disorders guided by functional MRI.

Authors:  Tonmoy Sharma
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

2.  Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry.

Authors:  Vicente Molina; Gemma Galindo; Benjamín Cortés; Alba G Seco de Herrera; Ana Ledo; Javier Sanz; Carlos Montes; Juan A Hernández-Tamames
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-28       Impact factor: 5.270

Review 3.  How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia?

Authors:  Katherine Seeber; Kristin S Cadenhead
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 5.285

4.  Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating.

Authors:  Erin A Hazlett; Monte S Buchsbaum; Jing Zhang; Randall E Newmark; Cathryn F Glanton; Yuliya Zelmanova; M Mehmet Haznedar; King-Wai Chu; Igor Nenadic; Eileen M Kemether; Cheuk Y Tang; Antonia S New; Larry J Siever
Journal:  Neuroimage       Date:  2008-07-11       Impact factor: 6.556

5.  Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia.

Authors:  Bjørn H Ebdrup; Birte Glenthøj; Hans Rasmussen; Bodil Aggernaes; Annika R Langkilde; Olaf B Paulson; Henrik Lublin; Arnold Skimminge; William Baaré
Journal:  J Psychiatry Neurosci       Date:  2010-03       Impact factor: 6.186

6.  Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment.

Authors:  E Zampieri; M Bellani; B Crespo-Facorro; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-22       Impact factor: 6.892

7.  Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental State.

Authors:  Daiki Sasabayashi; Yoichiro Takayanagi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Chika Obara; Masahiro Katsura; Naohiro Okada; Shinsuke Koike; Hidenori Yamasue; Mihoko Nakamura; Atsushi Furuichi; Mikio Kido; Yumiko Nishikawa; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; Kiyoto Kasai; Michio Suzuki
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 8.  [The concept of schizoidia in psychiatry : From schizoidia to schizotypy and cluster A personality disorders].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2017-07-11

9.  Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia.

Authors:  Martina Ballmaier; Florian Schlagenhauf; Arthur W Toga; Jürgen Gallinat; Michael Koslowski; Michele Zoli; Cornelius Hojatkashani; Katherine L Narr; Andreas Heinz
Journal:  Schizophr Res       Date:  2008-09-24       Impact factor: 4.939

10.  Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder.

Authors:  James J Levitt; Carl Fredrik Westin; Paul G Nestor; Raul S J Estepar; Chandlee C Dickey; Martina M Voglmaier; Larry J Seidman; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton
Journal:  Biol Psychiatry       Date:  2004-01-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.